1. Introduction
===============

While the development of drug resistance is perhaps the best-known evolutionary response to treatment programs, public health interventions may exert other selective pressures on pathogens. There has been mounting recognition of the need to understand the balance between the immediate epidemiological benefits and longer-term evolutionary risks of interventions ([@bib22], [@bib38], [@bib28], [@bib37]). Recent work has revealed that vaccines that reduce pathogen replication or toxicity favor increased virulence, while vaccines that reduce the susceptibility of hosts to infection select for lower levels of virulence ([@bib39], [@bib40]). Here we explore the effect of treatments that act by reducing the infectious period, such as curative therapy or case isolation measures, on the optimal virulence level of a pathogen.

The evolutionary fitness of a pathogen is quantified by its basic reproduction number ($R_{0}$), which is the average number of secondary cases generated by an initial infection in a susceptible population ([@bib1], [@bib60]). In the absence of within-host competition among pathogen strains ([@bib64]), the optimal virulence is determined by maximizing $R_{0}$ subject to trade-offs between epidemiological parameters that are affected by pathogen virulence ([@bib62], [@bib13]). However, the trade-off between disease-induced mortality (often taken as the definition of virulence) and pathogen transmissibility (assumed to increase with virulence) has been criticized as too simple ([@bib25]). Recent work on virulence evolution has explored the importance of host population structure ([@bib69], [@bib9], [@bib76]) and more complex interactions between epidemiological parameters ([@bib2], [@bib41]).

In this work, we define virulence as the extent of host resource exploitation by the pathogen, which correlates with harm to the host (and reduced fitness) ([@bib73], [@bib37], [@bib66]). We review evidence that as virulence increases, the host may be harmed in four ways: (1) increased mortality, (2) slower recovery from infection, (3) reduced activity, i.e. fewer contacts with other individuals, and (4) increased probability of transmission given a contact. Furthermore, as increasing pathogen virulence worsens symptoms, rates of treatment or isolation of infectious hosts may increase ([@bib77], [@bib78]). Thus, we consider evolution of pathogens with a wide range of disease manifestations, including non-lethal infectious diseases such as gonorrhea, and show under what circumstances curative therapy or case isolation may change the optimal virulence.

2. The reproduction number $R_{u}$
==================================

Denoting the level of disease control or treatment effort by *u*, the reproduction number $R_{u}$ is the number of secondary cases that would be generated by a single case in a wholly susceptible population in the presence of control at the level *u*. When there is no control and $u = 0$, $R_{u} = R_{0}$; increasing values of *u* denote increasing treatment effort. We define the effective contact rate *E* as the rate at which a susceptible produces new infectives in a wholly susceptible population; for the simple model of disease transmission ([@bib1], [@bib4], [@bib50]) discussed in the Appendix, $E = \beta c_{y}$, where $\beta$ is the transmission probability per contact and $c_{y}$ is the number of contacts per unit time; *E* is independent of treatment effort *u* in this model. The mean duration of infectivity *D* is given by ([@bib1])$$D = \frac{1}{\mu + \delta + \rho + \varphi(u)},$$where $\mu$ is the background removal rate, $\delta$ is the disease-specific mortality rate, $\rho$ is the recovery rate, and $\varphi(u)$ the per-capita removal rate due to treatment or case isolation. We assume that $\varphi$ always increases with the effort *u* and that $\varphi(0) = 0$. The reproduction number itself is then given simply by $R_{u}(v) = E(v)D(u,v)$ [@bib1]; this expresses the trade-off between the effective contact rate and the duration of transmission that determines the evolutionarily optimal level of virulence.

In this paper, we will introduce plausible functional forms for $\beta$, $c_{y}$, $\delta$, $\rho$, and $\varphi$ in terms of pathogen virulence *v*, and find explicit expressions for the optimal virulence levels for a set of disease-dependent special cases. This allows us to make predictions regarding the effect of treatment on optimal virulence levels, including cases where treatment rates are higher for more virulent pathogens. We will characterize how changes in treatment effort *u* affect the values $v^{*}$ for which $R_{u}(v)$ is maximized, and show that curative treatment influences optimal virulence by reducing the benefits the pathogen can obtain from strategies that increase the duration of infectiousness.

3. Pathogen strategies
======================

All else being equal, a pathogen benefits from a large transmissibility $\beta$ and host activity level $c_{y}$, and a small recovery rate $\rho$ and death rate $\delta$, thus maximizing both the effective contact rate and duration of infectivity. However, recent theory has emphasized that these parameters may not, in general, vary independently. For instance, increasing transmissibility may be possible only through enhanced virulence, which in turn may lead to an increased mortality or to reduced contact rate (see discussion in [@bib56]). We now review evidence for the dependence of disease-induced death rates, host activity levels, transmissibility, and recovery rates on the level of virulence.

The link between pathogen virulence and disease-induced mortality is clear. Indeed, in many studies virulence is defined as the increase in mortality rate due to disease ([@bib18]). In this study, we treat cases where disease mortality rates $\delta$ are linearly proportional to virulence (the standard assumption), or where the pathogen produces no disease-induced mortality, but harms the host in other ways.

As virulence is increased, the normal activities of the host may become increasingly impeded, leading to a potential reduction of the contact rate $c_{y}$ (e.g. ([@bib29], [@bib79], [@bib59])). Symptoms themselves may lead to behavioral changes (such as increased sleep, reduced sexual activity, and decreased mixing in the community) ([@bib24]) arising from pathogen resource exploitation or the cost of immune response ([@bib55]). We consider the case where host contact rate is a concave-up decreasing function of pathogen virulence.

Greater pathogen loads within hosts may yield higher transmission probability per contact ("transmissibility"), $\beta$, due to higher pathogen concentrations in bodily fluids or to more severe symptoms ([@bib29], [@bib54]). For example, coughing expels droplets which facilitate the spread of airborne infections such as influenza ([@bib52]) and tuberculosis ([@bib44]). Higher densities of pathogen should, all else being equal, result in a more virulent or harmful infection. Thus, a positive relationship between the transmissibility and virulence ([@bib10], [@bib62], [@bib29], [@bib56]) may occur in many host-pathogen systems, including *Schistosoma mansoni* ([@bib17]), trypanosomes ([@bib23]), influenza ([@bib83]), myxoma virus in rabbits ([@bib32], [@bib1]), Plasmodium species ([@bib61]), canine parvovirus ([@bib63]) and HIV ([@bib51], [@bib45], [@bib71], [@bib47], [@bib48], [@bib15], [@bib16], [@bib33], [@bib67]). We treat the case where transmissibility is a concave-down increasing function of virulence, where necessarily $0 \leqslant \beta(v) \leqslant 1$, with an independent parameter $\beta_{1}$ determining whether a completely avirulent strain ($v = 0$) is still transmissible (as are many commensal microorganisms ([@bib43])); see Eq. ([9](#fd9){ref-type="disp-formula"}) below for details.

Pathogens are under selection to evade immunity and hence prolong infection. For example, trypanosomes and malarial parasites undergo antigenic variation within single infections. Heightened virulence has been found to prolong the period of infectiousness in lizard malaria *Plasmodium mexicanum* ([@bib27]), myxoma virus in rabbits ([@bib32], [@bib1]), canine parvovirus ([@bib63]), *Bordetella avium* ([@bib75]), hepatitis B virus ([@bib34]) and influenza ([@bib83]). We explore the case in which the recovery rate $\rho$ is a decreasing (or at least non-increasing) function of the virulence parameter *v*. (Note that a recovery rate that increases with the virulence could be subsumed into the increasing mortality rate $\delta$ without loss of generality.)

4. Disease control strategy
===========================

We denote the level of disease control effort by *u*, such that the treatment rate $\varphi$ increases as *u* increases (i.e. $\frac{d\varphi}{du} > 0$), and $\varphi(u = 0) = 0$. The effect of treatment is to remove individuals from the infective class at rate $\varphi$; examples are tuberculosis ([@bib14]) and gonorrhea ([@bib20]) for curative therapy, or severe acute respiratory syndrome (SARS) ([@bib58]) and smallpox (e.g. [@bib65]) for case isolation. The treatment rate $\varphi$ may also be related to the virulence, since treatment should be sought more often as symptoms become more severe ([@bib77], [@bib78]). Severe symptoms may also increase control efforts for contact tracing, resulting in prophylactic treatment or quarantine, as occurred during the recent SARS outbreak (e.g. [@bib58]). We therefore consider the general case where $\varphi$ depends on *u* and *v*, as well as the special case of virulence-independent treatment.

5. The optimal virulence under treatment
========================================

We assume $v \geqslant 0$, so if $R_{u}$ decreases monotonically with *v*, the optimal virulence is $v^{*} = 0$. Otherwise, a local maximum of $R_{u}$ occurs at $v^{*}$ if$$\frac{\partial R_{u}}{\partial v}\,(u,v^{*}(u)) = 0$$and $$\frac{\partial^{2}R_{u}}{\partial v^{2}}\,(v^{*}) < 0.$$

The virulence level at which $R_{u}$ is maximized may also be found by substituting $R = \mathit{ED}$ into Eq. ([2](#fd2){ref-type="disp-formula"}) and finding the value $v^{*}$ which solves$$\frac{1}{E}\,\frac{\partial E}{\partial v} = - \frac{1}{D}\,\frac{\partial D}{\partial v}.$$This condition corresponds to that value of the virulence for which gains in effective contact rate are exactly balanced by losses in duration of infectivity, or vice versa. When the form of *E* is unimodal, let $v_{t}$ denote the value of *v* at which *E* is maximized; similarly, when *D* is unimodal in *v* for a particular *u*, we may denote by $v_{d}$ that value of *v* such that *D* is maximized. In the case of virulence-independent treatment, $v_{d}$ is independent of *u*.

We are interested in the sign of $\frac{dv^{*}}{du}$, i.e. does increasing treatment effort lead to higher or lower levels of optimal virulence? Differentiating Eq. ([2](#fd2){ref-type="disp-formula"}) with respect to *u* and rearranging leads to an expression for the dependence of the optimal virulence $v^{*}$ on the control variable *u*:$$\frac{dv^{*}}{du} = - \frac{\frac{\partial}{\partial u}\,\frac{\partial R_{u}}{\partial v}}{\frac{\partial^{2}R_{u}}{\partial v^{2}}}$$provided $\frac{\partial^{2}R_{u}}{\partial v^{2}} \neq 0$. If $v^{*}(u)$ corresponds to a local maximum of $R_{u}$ and $\frac{\partial^{2}R_{u}}{\partial v^{2}} \neq 0$, then $\frac{\partial^{2}R_{u}}{\partial v^{2}} < 0$. In this case, from Eq. ([4](#fd4){ref-type="disp-formula"}) we see that $\frac{dv^{*}}{du} > 0$ if and only if $\frac{\partial}{\partial u}\,\frac{\partial R_{u}}{\partial v} > 0$. Thus, if increases in the control variable *u* increase the marginal fitness with respect to the virulence, then the treatment program will increase the optimal virulence of the pathogen and thus provide a selective pressure for the pathogen virulence to increase.

To determine the sign of $\frac{\partial}{\partial u}\,\frac{\partial R_{u}}{\partial v}$ at the optimal virulence, we first observe that Eq. ([1](#fd1){ref-type="disp-formula"}) implies that $\frac{\partial D}{\partial u} = - D^{2}\,\frac{\partial\varphi}{\partial u}$, and since *E* has no explicit dependence on *u*, $\frac{\partial E}{\partial u} = 0$. Since, by definition, $R_{u} = \mathit{ED}$, $$\frac{\partial}{\partial u}\,\frac{\partial R_{u}}{\partial v} = E\left( {\frac{\partial}{\partial v}\,\frac{\partial D}{\partial u} + \frac{\partial D}{\partial u}\,\frac{1}{E}\,\frac{\partial E}{\partial v}} \right).$$Substituting $\frac{\partial D}{\partial u} = - D^{2}\,\frac{\partial\varphi}{\partial u}$ and rearranging leads to$$\frac{\partial}{\partial u}\,\frac{\partial R_{u}}{\partial v} = \mathit{ED}^{2}\left( {2\left( {- \frac{1}{D}\,\frac{\partial D}{\partial v}\,\frac{\partial\varphi}{\partial u}} \right) - \frac{\partial^{2}\varphi}{\partial u\,\partial v} - \frac{\partial\varphi}{\partial u}\,\frac{1}{E}\,\frac{\partial E}{\partial v}} \right).$$Eqs. ([3](#fd3){ref-type="disp-formula"}) and ([5](#fd5){ref-type="disp-formula"}) together imply that at $v^{*}$,$$\frac{\partial}{\partial u}\,\frac{\partial R_{u}}{\partial v} = \mathit{ED}^{2}\left( {\frac{1}{E}\,\frac{\partial E}{\partial v}\,\frac{\partial\varphi}{\partial u} - \frac{\partial}{\partial v}\,\frac{\partial\varphi}{\partial u}} \right).$$Hence for $E > 0$ and $D > 0$, and both *D* and *E* unimodal in *v*, Eq. ([6](#fd6){ref-type="disp-formula"}) implies that $\frac{\partial}{\partial u}\,\frac{\partial R_{u}}{\partial v} > 0$ if and only if$$\frac{1}{E}\,\frac{\partial E}{\partial v}\,(v^{*}(u)) > \frac{1}{\frac{\partial\varphi}{\partial u}\,(v^{*}(u),u)}\,\frac{\partial}{\partial v}\,\frac{\partial\varphi}{\partial u}\,(u,v^{*}(u)).$$Therefore, from condition ([4](#fd4){ref-type="disp-formula"}), $\frac{dv^{*}}{du} > 0$ if and only if Eq. ([7](#fd7){ref-type="disp-formula"}) holds. That is, the optimal virulence increases with greater treatment effort if and only if the relative increase in *E* per unit increase in *v* outweighs the relative increase in the marginal treatment rate $\frac{\partial\varphi}{\partial u}$.

6. Virulence-independent treatment
==================================

In the case of virulence-independent treatment, $\frac{\partial}{\partial v}\,\frac{\partial\varphi}{\partial u} = 0$. Since by assumption $\frac{\partial\varphi}{\partial u} > 0$ (and $E(v^{*}) > 0$), it follows from ([7](#fd7){ref-type="disp-formula"}) that $\frac{dv^{*}}{du} > 0$ if and only if$$\frac{\partial E}{\partial v}\,(v^{*}) > 0.$$In the example shown in [Fig. 1](#fig1){ref-type="fig"} , unimodal curves for *E* and *D* are plotted from the functional forms for parameters proposed below. The optimal virulence $v^{*}$ occurs at the unique intersection of the $e \equiv \frac{1}{E}\,\frac{\partial E}{\partial v}$ and $d \equiv - \frac{1}{D}\,\frac{\partial D}{\partial v}$ curves (Eq. ([3](#fd3){ref-type="disp-formula"})); in [Fig. 1](#fig1){ref-type="fig"}A, $\frac{\partial E}{\partial v}\,(v^{*}) > 0$ and $v_{t} > v_{d}$, whereas in [Fig. 1](#fig1){ref-type="fig"}B, $\frac{\partial E}{\partial v}\,(v^{*}) < 0$ and $v_{t} < v_{d}$. Two curves for *d* are shown: the dashed curve $d_{2}$ corresponds to a higher treatment rate $\varphi$ than the solid curve $d_{1}$. Increasing treatment flattens the *d*-curve, and shifts the optimal virulence away from the duration maximizing value $v_{d}$ and toward the transmission-rate maximizing value $v_{t}$. Hence, the optimal virulence increases when $v_{t} > v_{d},$ and decreases when $v_{t} < v_{d}$. The figure illustrates the following proposition (proven in the appendix).PropositionIf treatment rates are independent of pathogen virulence, and *D* and *E* are differentiable and unimodal, with $v_{t}$ being the point at which the maximum of *E* occurs, and $v_{d}$ being the point at which the maximum of *D* occurs (being independent of *u*), then $\frac{dv^{*}}{du}$ has the same sign as $v_{t} - v_{d}$. Fig. 1Virulence dependence of the relative rate of change of the effective contact rate ($e \equiv \frac{1}{E}\,\frac{\partial E}{\partial v}$) and the duration ($d \equiv - \frac{1}{D}\,\frac{\partial D}{\partial v}$, where the solid line $d_{1}$ and dashed line $d_{2}$ correspond to lower and higher treatment rates, respectively.) The curves correspond to the case $E(v) = E_{1}(v) = \left( {\frac{(\beta_{0} - \beta_{1})v}{v + v_{0}} + \beta_{1}} \right)\frac{c_{0}v_{1}}{v + v_{1}}$ and $D(v,u) = D_{1}(v,u) = \frac{1}{\mu + \varphi(u) + \delta_{0}v + \frac{\rho_{0}v_{3}}{v + v_{2}}}$. (A) Increasing treatment increases the optimal virulence, since the dashed line $d_{2}$ intersects the *e*-curve at larger virulence. (Parameter values: $\delta_{0} = 0.2$ per unit time, $\rho_{0} = 0.1$ per unit time, $\beta_{0} = 0.3$, $\beta_{1} = 0$,$v_{0} = 5$, $c_{0} = 20$ per unit time, $v_{1} = 2$, $v_{2} = 0$, $v_{3} = 1$; for the low treatment line, $\mu + \varphi = 0.05$ per unit time, and for the high treatment dashed line, $\mu + \varphi = 0.3$ per unit time.) (B) Increasing treatment decreases the optimal virulence, since the dashed line $d_{2}$ intersects the *e*-curve for smaller values of *v*. (Parameter values: as in A except $\delta_{0} = 0.005$ per unit time.)

At the value $v_{t}$ that maximizes transmission, increasing the virulence decreases the effective contact rate (*E*), but produces a larger proportional increase in the duration of infectivity (*D*), so the overall product $R_{u} = \mathit{ED}$ is larger ([Fig. 2](#fig2){ref-type="fig"} ). The effect of treatment is to reduce the potential proportional increase in the duration that is possible by changes in virulence, and by reducing the value of "trading off" transmission for duration, to shift the overall optimum $v^{*}$ (upwards or downwards) toward the transmission-rate maximizing value $v_{t}$. Hence, as the treatment rate $\varphi$ increases, recovery and mortality become less important as determinants of duration.Fig. 2Relationship between $v_{t}$, $v_{d}$, and $v^{*}$ as indicated on a parametric plot of the effective contact rate $E(v)$ and the duration of infectivity $D(v)$ as a function of the virulence; the dashed curves are contours of $R_{u}$. At the points labeled $v_{t}$ and $v_{d}$ the effective contact rate and duration of infectivity are maximized, respectively. At the point labeled $v^{*}$, the reproduction number is maximized. The solid curve corresponds to the case $E(v) = E_{1}(v)$ and $D(v) = D_{1}(v)$ as given in [Fig. 1](#fig1){ref-type="fig"}, with parameters as in [Fig. 1](#fig1){ref-type="fig"}A.

Based on the empirical evidence outlined above, plausible functional forms for the four epidemiological parameters are as follows:$$\beta(v) = \frac{(\beta_{0} - \beta_{1})v}{v + v_{0}} + \beta_{1},$$ $$c_{y}(v) = \frac{c_{0}v_{1}}{v + v_{1}},$$ $$\delta(v) = \delta_{0}v$$and$$\rho(v) = \frac{\rho_{0}v_{3}}{v + v_{2}}.$$For the most general case, the change in optimal virulence as the treatment level increases is illustrated numerically for a range of values of $\beta_{1}$ (the transmission probability when $v = 0$) in [Fig. 3](#fig3){ref-type="fig"} . When $\beta_{1} = 0$, the optimal virulence increases as the treatment level increases; by the time $\beta_{1} = 0.1$, the optimal virulence decreases as the treatment level increases.Fig. 3Changes in optimal virulence due to increasing treatment for the case $E(v) = E_{1}(v)$ and $D(v) = D_{1}(v)$ (as given in [Fig. 1](#fig1){ref-type="fig"}) are illustrated for a range of values of $\beta_{1}$ (indicated above each curve). Other parameter values are $\beta_{0} = 0.3$, $v_{0} = 5$, $c_{0} = 20$ per unit time, $v_{1} = 2$, $\delta_{0} = 0.025$ per unit time, $\rho_{0} = 0.25$ per unit time, $\mu = 0.01$ per unit time, $v_{2} = 0.3$, and $v_{3} = 0.35$.

7. Special cases
================

There are six simple special cases in which two of the four parameters $\beta$, $c_{y}$, $\rho$, and $\delta$ vary with the virulence ([Table 1](#tbl1){ref-type="table"} ). In the transmissibility-recovery case, the transmissibility $\beta$ and the recovery rate $\rho$ are functions of virulence and $c_{y}$ and $\delta$ are constant; then the optimal virulence $\left. v^{*}\rightarrow\infty \right.$. In the contact-mortality case, the contact rate $c_{y}$ decreases with virulence and the mortality rate $\delta$ increases with the virulence, but $\beta$ and $\rho$ remain constant; here, $v^{*} = 0$. More interesting are the four remaining cases.Table 1Special casesScenario$\beta(v)$$c_{y}(v)$$\delta(v)$$\rho(v)$$v^{*}$TR$\frac{(\beta_{0} - \beta_{1})v}{v + v_{0}} + \beta_{1}$$c_{0}$ (constant)0$\frac{\rho_{0}v_{3}}{v + v_{2}}$$\infty$CM$\beta_{0}$ (constant)$\frac{c_{0}v_{1}}{v + v_{1}}$$\delta_{0}v$00CT$\frac{(\beta_{0} - \beta_{1})v}{v + v_{0}} + \beta_{1}$$\frac{c_{0}v_{1}}{v + v_{1}}$00$v_{t} = \frac{- \beta_{1}v_{0} + \sqrt{v_{0}(\beta_{0} - \beta_{1})(\beta_{0}v_{1} - \beta_{1}v_{0})}}{\beta_{0}}$RM$\beta_{0}$ (constant)$c_{0}$ (constant)$\delta_{0}v$$\frac{\rho_{0}v_{3}}{v + v_{2}}$$v_{d} = \max\left( {0\operatorname{,-}v_{2} + \sqrt{\frac{\rho_{0}v_{3}}{\delta_{0}}}} \right)$CR$\beta_{0}$ (constant)$\frac{c_{0}v_{1}}{v + v_{1}}$0$\frac{\rho_{0}v_{3}}{v + v_{2}}$Eq. ([14](#fd14){ref-type="disp-formula"})TM$\frac{(\beta_{0} - \beta_{1})v}{v + v_{0}} + \beta_{1}$$c_{0}$ (constant)$\delta_{0}v$0Eq. ([15](#fd15){ref-type="disp-formula"})

*Contact--Transmissibility Trade-off* (*CT*): In this case, the transmissibility $\beta$ increases and the contact rate $c_{y}$ decreases as the virulence increases, while the duration of infectivity is independent of virulence ([Table 1](#tbl1){ref-type="table"}). The optimal virulence maximizes the effective contact rate: $v^{*} = v_{t} = \frac{- \beta_{1}v_{0} + \sqrt{v_{0}(\beta_{0} - \beta_{1})(\beta_{0}v_{1} - \beta_{1}v_{0})}}{\beta_{0}}$ and does not depend on the treatment rate. Such a scenario may occur when the duration of infectivity is determined by the time required for the host to mount a sufficient immune response.

*Recovery--Mortality Trade-off* (*RM*): In this scenario, the mortality rate increases and the recovery rate decreases as pathogen virulence increases ([@bib10], [@bib46], [@bib62], [@bib80]), but neither the transmissibility nor the contact rate depend on the virulence ([Table 1](#tbl1){ref-type="table"}). Here, the optimal virulence is the duration maximizing value $v^{*} = v_{d} = \max\left( {0\operatorname{,-}v_{2} + \sqrt{\frac{\rho_{0}v_{3}}{\delta_{0}}}} \right)$ and does not depend on the treatment rate; increasing treatment results in shorter durations of infectivity, but the optimum virulence is unaffected.

*Contact--Recovery Trade-off* (*CR*): In this case, as the pathogen becomes more virulent, the contact rate and the recovery rate decrease. We assume that the transmissibility and mortality rates are not dependent on the virulence ($\delta_{0} = 0$, without loss of generality) as shown in [Table 1](#tbl1){ref-type="table"}; the maximum effective contact rate is attained at $v_{t} = 0$; the maximum duration of infectivity is attained as $\left. v_{d}\rightarrow\infty \right.$. In this case, $R_{u}$ decreases in *v* for $v \geqslant 0$, provided$$\varphi > \frac{\rho_{0}v_{3}(v_{1} - v_{2})}{v_{2}^{2}} - \mu.$$Since $\varphi$ is positive, Eq. ([13](#fd13){ref-type="disp-formula"}) is always satisfied whenever $v_{1} \leqslant v_{2}$; whenever Eq. ([13](#fd13){ref-type="disp-formula"}) is satisfied, $v^{*} = 0$. When Eq. ([13](#fd13){ref-type="disp-formula"}) is not satisfied, the optimal virulence is given by$$v^{*} = \max\left( {0\operatorname{,-}v_{2} + \sqrt{\frac{\rho_{0}v_{3}(v_{1} - v_{2})}{\mu + \varphi}}} \right).$$The value of $v^{*}$ never increases with treatment intensity $\varphi$. When $\frac{\rho_{0}v_{3}(v_{1} - v_{2})}{v_{2}^{2}} - \mu < 0$, the optimal virulence is always zero, no matter what the treatment level is. This is because ([13](#fd13){ref-type="disp-formula"}) is satisfied for all $\varphi$ and $R_{u}$ must be monotone decreasing. If $v_{2} = 0$, so that $\rho = \frac{\rho_{0}v_{3}}{v}$, then $v^{*} = \sqrt{\frac{\rho_{0}v_{1}v_{3}}{\mu + \varphi}}$, which is always positive and strictly decreases as $\varphi$ increases; increasing treatment results in a decreasing optimal virulence.

*Transmission--Mortality Trade-off* (*TM*): We extend the standard assumption of a positive relationship between increased transmissibility and increased mortality ([@bib10], [@bib11], [@bib18], [@bib35], [@bib56], [@bib57], [@bib74], [@bib81], [@bib36]) to include effects of treatment (see [Table 1](#tbl1){ref-type="table"}). As the virulence increases, the transmission rate increases, and the maximum effective contact rate is attained as $\left. v_{t}\rightarrow\infty \right.$. If the recovery rate is also unaffected and the mortality rate increases with the virulence according to the assumptions given in [Table 1](#tbl1){ref-type="table"}, then as the virulence increases, the duration of infectivity decreases ([@bib10], [@bib53]); the maximum duration of infectivity is attained at $v_{d} = 0$. The optimal virulence is given by$$v^{*} = \max\left( {0,\,\frac{- v_{0}\beta_{1}\delta_{0} + \sqrt{\delta_{0}v_{0}(\beta_{0} - \beta_{1})(\beta_{0}(\mu + \varphi) - v_{0}\beta_{1}\delta_{0})}}{\delta_{0}\beta_{0}}} \right)$$whenever the term under the radical is nonnegative, and zero otherwise. Here, $v^{*}$ never decreases as $\varphi$ increases (or equivalently, since $\varphi$ increases as the control effort *u* increases, $\frac{dv^{*}}{du} \geqslant 0$). In this case, the transmission-rate maximizing value $\left. v_{t}\rightarrow\infty \right.$, and the duration maximizing value $v_{d} = 0$. Since the duration maximizing value $v_{d}$ is below the transmission-rate maximizing value $v_{t}$, increasing levels of treatment lead to a nondecreasing optimal virulence. In particular, whenever $\varphi > \frac{v_{0}\beta_{1}\delta_{0}}{\beta_{0} - \beta_{1}} - \mu$, the optimal virulence is greater than zero, and increases as $\varphi$ increases. Observe that whenever $\frac{v_{0}\beta_{1}\delta_{0}}{\beta_{0} - \beta_{1}} - \mu > 0$, the optimal value of *v* is zero for low treatment values, and remains so until $\varphi$ has become sufficiently large.

The increase in optimal virulence with treatment for the case TM is illustrated in a standard graphical approach to determine the evolutionarily stable level of virulence ([@bib22]) ([Fig. 4](#fig4){ref-type="fig"} A). For simplicity, we assume $\beta_{1} = 0$ for this figure, so that $v^{*} = \sqrt{\frac{v_{0}(\mu + \varphi)}{\delta_{0}}}$. The curve shows values for which the relationship $\beta(v) = \frac{\beta_{0}v}{v + v_{0}}$ is satisfied. All values of *v* and $\beta$ for which the reproduction number $R_{u}$ takes on any particular value lie on a straight line; steeper slopes correspond to larger $R_{u}$, and the *v*-intercept is determined by the treatment rate $\varphi$ ($v_{\mathit{int}}) = - \frac{\mu + \rho + \varphi}{\delta_{0}}$. For concave-down $\beta(v)$ curves, the optimal virulence $v^{*}$ is the virulence level corresponding to the point of tangency---where the slope is steepest. As $\varphi$ increases under virulence-independent treatment, the intercept moves left, but the point of tangency moves right (the optimal virulence increases).Fig. 4Changes in optimal virulence due to increasing treatment for the transmissibility-mortality case (the case TM in [Table 1](#tbl1){ref-type="table"}). The solid curved line in each case shows $\beta(v)$; the straight lines show combinations of $\beta$ and *v* corresponding to constant values of $R_{u}$ (see text for details). (A) For the case of virulence-independent treatment, the high-treatment dashed line intersects the $\beta(v)$ curve for higher values of the virulence than the low-treatment solid line. (Parameter values: $c_{0} = 20$ per unit time, $\delta_{0} = 0.1$, $\beta_{0} = 0.3$, $\beta_{1} = 0$, $v_{0} = 5$, $\rho = 0$; for the solid line, $\mu + \varphi = 0.1$ per unit time and $R_{u} = 5.7$; for the dashed line, $\mu + \varphi = 0.3$ per unit time and $R_{u}$=3.9.) (B) Virulence-dependent treatment illustrated for $\varphi = k^{\prime}\mathit{uv}$; the dashed line corresponds to the largest possible value of $R_{u}$ for the given $\beta$-*v* relationship. The point of tangency occurs at a lower value of virulence: increasing treatment rates for more virulent organisms outweighs the benefit of increased transmission rates, and so increasing treatment effort reduces the optimal virulence. (Parameter values: same as for part A, except $\mu = 0.1$ per unit time, $k^{\prime} = 1$ and $u = 0$ for the solid line and $u = 0.1$ for the dashed line.)

In general, continuity of $R_{u}$ does not guarantee continuity of the value of *v* which maximizes is, as a function of *u* ([@bib5]). A simple numerical example is provided by $$\beta(v) = \beta_{1} + H(v - \hat{v})\,\frac{(\beta_{0} - \beta_{1})(v - \hat{v})}{v - \hat{v} + v_{0}},$$ $c = c_{0}v_{1}/(v + v_{1})$, $\rho(v) = \rho_{0}$, $\delta(v) = \delta_{0}v$, $\varphi = \mathit{ku}$, and $H(x)$ denotes the unit step function. Letting $c_{0} = 20$, $v_{1} = 2$, $\beta_{0} = 0.4$, $\beta_{1} = 0.06$, $v_{0} = 2$, $\hat{v} = 1$, $\rho_{0} = 0.1$, $\delta_{0} = 0.2$, and $k = 1$, we find that the product $R_{u} = \mathit{ED}$ is bimodal, and the value $v^{*}$ that optimizes $R_{u}$ jumps from 0 to approximately 2.09 at $u \approx 0.8$. Near this value, small additional increases in the control effort cause large changes in the optimal virulence.

8. Virulence-dependent treatment
================================

While selective pressure due to increased treatment of more virulent strains of a pathogen may be expected to reduce the optimal virulence ([@bib37]), Eq. ([7](#fd7){ref-type="disp-formula"}) shows that it is possible for treatment to increase the optimal virulence even when more virulent strains are treated more rapidly than less virulent strains. Large positive values for $\frac{\partial}{\partial v}\,\frac{\partial\varphi}{\partial u}$ reverse the inequality in Eq. ([7](#fd7){ref-type="disp-formula"}) so that increasing treatment reduces the optimal virulence. Small positive values of $\frac{\partial}{\partial v}\,\frac{\partial\varphi}{\partial u}$ would result in slight increases or decreases in the optimal virulence.

8.1. Example
------------

The bilinear form $\varphi(u,v) = k^{\prime}\mathit{uv}$ provides a simple functional form in which the treatment rate $\varphi$ increases with increasing control effort *u* and with the virulence *v*; substituting in Eq. ([7](#fd7){ref-type="disp-formula"}) reveals that the qualitative effect of treatment on optimal virulence levels is determined by how the effective contact rate $E(v)$ and marginal treatment rate $\frac{\partial\varphi}{\partial u}$ vary with pathogen virulence. We first assume that virulence affects both contact rates $c_{y}$ and transmissibility $\beta$ according to Eqs. ([9](#fd9){ref-type="disp-formula"}) and ([10](#fd10){ref-type="disp-formula"}). Since $\frac{\partial\varphi}{\partial u} = k^{\prime}v$, the right-hand side of Eq. ([7](#fd7){ref-type="disp-formula"}) is $\frac{1}{v}$; it can then be shown that $\frac{1}{E}\,\frac{\partial E}{\partial v} - \frac{1}{v} < 0$ for any positive $v = v^{*}$; Eq. ([7](#fd7){ref-type="disp-formula"}) is not satisfied, and increasing treatment necessarily results in a decrease in the optimal virulence when $\varphi(u) = k^{\prime}\mathit{uv}$. The same result holds when only $c_{y}$ or only $\beta$ depends on virulence.

We next reconsider in detail the special case TM (using the parameters in [Table 1](#tbl1){ref-type="table"}), under the assumption that the treatment rate increases with pathogen virulence according to $\varphi = k^{\prime}\mathit{uv}$. If$$\beta_{0}\beta_{1}v_{0}k^{\prime}u + \beta_{0}\beta_{1}\delta_{0} + \beta_{0}\beta_{1}\mu - \beta_{0}^{2}\mu < 0,$$then the optimal virulence is given by $$v^{*} = - \frac{v_{0}\beta_{1}}{\beta_{0}} + \sqrt{\frac{v_{0}(\beta_{0} - \beta_{1})}{\beta_{0}^{2}}\left( {\frac{\mu\beta_{0}}{k^{\prime}u + \delta_{0}} - v_{0}\beta_{1}} \right)},$$which decreases as *u* increases. As *u* increases, the left-hand side of the inequality ([16](#fd16){ref-type="disp-formula"}) increases, until finally it becomes greater than zero. When this occurs and inequality ([16](#fd16){ref-type="disp-formula"}) is not satisfied, $R_{u}$ monotonically decreases in *v*, and the optimal virulence is given by $v^{*} = 0$. Further increases in *u* continue to increase the left hand side of the inequality ([16](#fd16){ref-type="disp-formula"}), but cannot further decrease $v^{*}$ below 0. If $\beta_{1} = 0$, the optimal virulence reduces to $$v^{*} = \sqrt{\frac{\mu v_{0}}{k^{\prime}u + \delta_{0}}},$$which decreases monotonically for all *u* and approaches 0 as $\left. u\rightarrow\infty \right.$. For a TM trade-off and $\varphi = k^{\prime}\mathit{uv}$, therefore, increasing treatment effort *u* always causes decreases in the optimal virulence level $v^{*}$; this contrasts with the above results for a TM trade-off under virulence-independent treatment, for which $\frac{dv^{*}}{du} > 0$ (Eq. ([15](#fd15){ref-type="disp-formula"})).

This case (TM trade-off with $\varphi = k^{\prime}\mathit{uv}$ and $\beta_{1} = 0$) is illustrated in [Fig. 4](#fig4){ref-type="fig"}B. As in [Fig. 4](#fig4){ref-type="fig"}A, the curve shows the relationship $\beta(v)$ and straight lines show combinations of $\beta$ and *v* that yield fixed values of $R_{u}$. Steeper lines correspond to higher values of $R_{u}$, and the optimal virulence (for a given *v*-intercept) is determined by the point of tangency. For $\varphi = k^{\prime}\mathit{uv}$, the *v*-intercept of the constant-$R_{u}$ lines is $v_{\mathit{int}} = - \frac{\mu + \rho}{k^{\prime}u + \delta_{0}}$. Increasing treatment effort *u* shifts the *v*-intercept to the *right* and causes the optimal virulence to decrease, as can be seen by comparing the dashed line (virulence-dependent treatment following $\varphi = k^{\prime}\mathit{uv}$) to the solid line (no treatment).

Other simple formulations of virulence-dependent treatment rates can yield opposite results, though, contrary to the intuitive expectation that targeting more virulent strains will exert selective pressure to decrease virulence. We illustrate with a simple example: $\varphi(u,v) = u(k + k^{\prime}v)$. When $\varphi(u,v) = u(k + k^{\prime}v)$, the optimal virulence is given by$$v^{*} = \sqrt{\frac{(\mu + \mathit{ku})v_{0}}{\delta_{0} + k^{\prime}u}}.$$First note that when $k^{\prime} = 0$ treatment is virulence-independent, and increasing the treatment rate increases the optimal virulence as in [Fig. 4](#fig4){ref-type="fig"}A. When $k^{\prime} > 0$, the outcome depends on the relative magnitude of the virulence-dependent and -independent components of $\varphi$ (i.e. $k^{\prime}$ versus *k*). When $k^{\prime} > \frac{k\delta_{0}}{\mu}$, increasing the treatment rate will decrease the optimal virulence. When $k^{\prime} < \frac{k\delta_{0}}{\mu}$, however, the treatment rate does not increase fast enough as virulence increases, and so increasing treatment leads to higher optimal virulence for the pathogen (i.e. the same qualitative behavior as the virulence-independent treatment case). Therefore, faster treatment of more virulent strains does not always exert sufficient selective pressure for increasing treatment effort to decrease the optimal virulence; the benefit to the pathogen of increased transmissibility can outweigh the cost of the higher treatment rate.

9. Discussion
=============

The optimal virulence of a pathogen may either increase or decrease in response to treatments that reduce the duration of infectivity, such as curative therapy and case isolation. Under the prevalent theory of virulence evolution, pathogen virulence evolves according to a trade-off between maximizing the number of new cases generated per unit time and maximizing the duration of infectivity. Treatment interventions reduce the value of duration-increasing strategies. Consequently, treatment shifts the optimal virulence toward values which produce larger numbers of new cases per unit time. This may result in increases or decreases of optimal virulence levels, depending on whether the virulence level that maximizes duration (independent of transmission) is below or above the virulence level that maximizes transmission (independent of duration). We applied this result to several special cases, extending trade-off models of previous authors, for the situation where treatment rates are independent of pathogen virulence. We found that when virulence is subject to a transmissibility-mortality trade-off, increasing treatment would lead to an increase in optimal virulence, but that in other cases optimal virulence is decreased (e.g. for the contact--recovery trade-off) or unaffected (e.g. for the recovery--mortality and contact-transmissibility trade-offs) by increasing treatment rates.

Our analysis reveals the possibility that virulence-dependent treatment rates (i.e. faster treatment for more virulent pathogen strains) may counteract evolutionary pressures toward increased virulence, providing an additional benefit to such policies ([@bib37]). The model can be extended to explore different modes of intervention (for instance, partially effective therapy or infection control measures that reduce transmissibility instead of duration; c.f. ([@bib39], [@bib40])) or availability of treatment (such as fixed delays rather than competing exponential risks ([@bib7])). A further extension could treat sociological effects of treatment availability, such as increasing contact rates or more risky behavior (e.g. [@bib6]).

In the most general setting, including coinfection or within-host competition between different strains, strains with the largest reproduction number may not prevail. Within-host competition may lead to increases in the virulence of a pathogen beyond what would optimally maximize the reproduction number ([@bib10], [@bib64], [@bib68], [@bib82], [@bib80], [@bib84]), although this escalation may be moderate as shown by the intermediate virulence reached by rabbit myxoma ([@bib31], [@bib32], [@bib30]). Our model could be extended to include a fitness function which incorporates within-host competition ([@bib70]), though in this case host demography may also need to be considered ([@bib12]). Other limitations of $R_{0}$ maximization have been raised ([@bib21]), including that virulence levels may be coincidental (e.g. [@bib54]), but it is still a productive approach to the study of optimal virulence (e.g. [@bib39], [@bib9]). Within this adaptive framework, we seek to determine the strategy that is evolutionarily optimal to the pathogen under specified model assumptions, but are limited in our predictions of whether such an optimum will actually be reached.

We have defined virulence as the extent of host exploitation by the pathogen, and used it as a driving variable for four epidemiological parameters. This framework is appropriate for pathogens with greatly differing natural histories, including non-lethal diseases (e.g. gonorrhea) that are excluded by narrower definitions of virulence that pertain only to disease-induced death. Furthermore the validity of a simple trade-off between mortality and transmissibility has been challenged ([@bib25], [@bib26]). We have reviewed the empirical evidence for more general trade-offs between epidemiological parameters (see also [@bib19]), and presented analysis of this general case. Our study is also the first, to our knowledge, to explicitly consider the link between virulence and host contact rates. The functional dependence of epidemiological parameters on virulence, however, is difficult to ascertain empirically. A recent study found dramatic differences in virulence evolution among models with markedly different formulations of transmission and host death, suggesting that detailed quantitative understanding of particular host--parasite interactions is required to reliably predict virulence evolution ([@bib41]). In this paper, we first presented general results applicable to arbitrary functional formulations, then explored examples based on plausible functional forms and special cases representing broad classes of disease natural histories.

The models presented in this paper show that treatment programs may either increase or decrease the optimal virulence of a pathogen, depending on details of the host--pathogen interaction. In conjunction with recent work on vaccination ([@bib39], [@bib40]) and drug resistance ([@bib8]), this study is a step toward understanding the evolutionary consequences of public health interventions. Further research, particularly empirical and interdisciplinary work, may enable evolutionary theory of pathogens to constructively inform public health decision-making.

A.1. Transmission model
-----------------------

Denoting the number of susceptible individuals by *X*, the number of infected individuals by *Y*, and the number of removed individuals by *Z*, a simple epidemic model is as follows: $$\overset{˙}{X} = \Lambda - \mu X - \beta c_{x}p_{\mathit{xy}}X,$$ $$\overset{˙}{Y} = \beta c_{x}p_{\mathit{xy}}X - (\mu + \delta + \rho + \varphi)Y,$$ $$\overset{˙}{Z} = (\rho + \varphi)Y - \mu Z$$where $\Lambda$ is the inflow rate of new susceptibles, $\mu$ is the per-capita background removal rate, $\beta$ is the probability of pathogen transmission given a contact between a susceptible and an infective, $c_{x}$ is the contact rate per susceptible or recovered individual, $c_{y}$ is the contact rate per infected individual, $\delta$ is the per-capita disease-induced mortality rate, $\rho$ is the per-capita recovery rate from disease, $\varphi$ is the per-capita treatment rate, and $p_{\mathit{xy}}$ is the probability that a susceptible will choose an infective partner: $$p_{\mathit{xy}} = \frac{c_{y}Y}{c_{x}X + c_{y}Y + c_{x}Z}.$$

Using standard arguments ([@bib1], [@bib4], [@bib50]), the basic reproduction number for this model is $R_{0} = \frac{\beta c_{y}}{\rho + \mu + \delta + \varphi}$, which is the product of the effective contact rate $E = \beta c_{y}$ and the duration of infectivity $D = 1/(\rho + \mu + \delta + \varphi)$. The parameters $c_{y}$, $\beta$, $\delta$, or $\rho$ may be affected by the pathogen virulence *v*, and $\varphi$ is affected by the level of treatment effort *u* (and possibly *v* as well); we define the reproduction number in the presence of treatment effort *u* as $R_{u} = \frac{\beta c_{y}}{\rho + \mu + \delta + \varphi(u)} = E(v)D(u,v)$. Since it arises from a linearization of the differential equations shown above, this definition of $R_{u}$ implicitly assumes an infinite (and hence non-depleting) pool of susceptibles available to be infected by the index case. Recent work has shown that using a finite contact neighborhood places an upper bound on the reproduction number, and that the standard formulation of $R_{0}$ is an overestimate compared to the value obtained when the susceptible pool is minimal ([@bib49], [@bib3]). This effect is strictly quantitative (i.e. it determines how much $R_{0}$ changes as parameters are varied, but not the direction of those changes), so qualitative conclusions of our study are unlikely to be affected. The impact on quantitative predictions of our analysis (e.g. values of $v^{*}$ for different special cases) will be limited in most cases, because values of $R_{u}$ are constrained to a limited range by trade-offs between parameters. An exception is the case TR in [Table 1](#tbl1){ref-type="table"}, for which limiting effects such as finite contact neighborhood will prevent the optimal virulence from approaching infinity.

In a system of multiple strains, competition dynamics determine which strain will dominate (and hence the level of optimal virulence). Using the established technique for epidemic models without coinfection ([@bib11], [@bib72], [@bib62]), we have verified for this model that the pathogen strain with the largest reproduction number $R_{u}$ is able to invade and competitively exclude all other strains ([@bib42]). Furthermore, there is no coexistence equilibrium for this model except in the special case where two strains have exactly equal reproduction numbers.Proof of PropositionLet $\frac{d}{du}\, v^{*} > 0$. Then, by Eq. ([8](#fd8){ref-type="disp-formula"}), $\frac{\partial E}{\partial v}\,(v^{*}(u)) > 0$, and then by Eq. ([3](#fd3){ref-type="disp-formula"}), $\frac{\partial D}{\partial v}\,(u,v^{*}(u)) < 0$. Since $E(v)$ is unimodal and nonnegative, $\frac{\partial E}{\partial v}$ has one zero at $v_{t}$, and $v < v_{t}$ if and only if $\frac{\partial E}{\partial v} > 0$. Thus, since $E_{v}(v^{*}(u)) > 0$, $v^{*}(u) < v_{t}$. A similar argument shows that $v_{d} < v^{*}$. Thus, $v_{d} < v^{*}(u) < v_{t}$, and so $v_{d} < v_{t}$.Similarly, if $\frac{d}{du}v^{*}(u) < 0$, $v_{t} < v_{d}$, and if $\frac{d}{du}v^{*}(u) = 0$, $v_{d} = v_{t}$.
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